Hana Pharm Co., Ltd. (KRX:293480)
South Korea · Delayed Price · Currency is KRW 8,400.00
+100.00 (1.20%)
At close: Oct 2, 2026
Hana Pharm Market Cap
Hana Pharm has a market cap or net worth of 149.29 billion as of October 2, 2026. Its market cap has decreased by -29.41% in one year.
Market Cap
149.29B
Enterprise Value
n/a
Revenue
139.33B
Ranking
n/a
PE Ratio
3.74
Stock Price
8,400.00
ChartMarket Cap Chart
Since October 2, 2018, Hana Pharm's market cap has decreased from 537.03B to 149.29B, a decrease of -72.20%. That is a compound annual growth rate of -14.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 149.29B | -25.13% |
| Dec 30, 2025 | 199.41B | 2.94% |
| Dec 30, 2024 | 193.73B | -21.86% |
| Dec 28, 2023 | 247.93B | -23.56% |
| Dec 29, 2022 | 324.36B | -9.43% |
| Dec 30, 2021 | 358.12B | -14.15% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chong Kun Dang Holdings | 178.28B |
| Samil Pharmaceutical Co.,Ltd | 175.24B |
| JW Lifescience | 171.26B |
| Daewon Pharmaceutical | 169.11B |
| Daihan Pharmaceutical | 154.94B |
| Ilsung Is | 153.67B |
| Jeil Pharmaceutical Co.,Ltd | 146.15B |
| Ilyang Pharmaceutical Co.,Ltd | 145.37B |